Hemant Vishwakarma THESEOBACKLINK.COM hello@theseobacklink.com
Email Us - hemantx96@gmail.com
directory-link.com | webdirectorylink.com | smartseobacklink.com

Links -> Link Details

Title Actinium’s iomab complete analysis.
URL https://mellalta.com/actiniums-multi-billion-dollar-market-for-targeted-conditioning-with-their-revolutionary-antibody-warhead-enabling-awe-platform/
Category Fitness Health --> Conditions and Diseases
Meta Keywords Actinium pharmaceutical, iomab-B, Sierra tirals, AWE platform, Actinium’s AWE platform, ATNM, ATNM stalks, ATNM trials, SIERRA trials, Actinium’s CD45, BMT, AML, Bone marrow transplant (BMT), Actinium’s iomab-B
Meta Description Actinium Pharmaceuticals is a clinical stage biopharmaceutical company, with an impressive Antibody Warhead Enabling (AWE) technology. The technology enables the development of breakthrough Antibody Radiation-Conjugates (ARCs)
Owner Emma Stones
Actinium’s clinical program which are still ongoing have already shown some high efficacy and what we, Mellalta Meets could say, that the promising new platform of AWE based target conditioning therapies and their unique combination approach is going to be something to keep an eye for, as the company looks for BLA submission for its lead product by 2021-2022